Interview At AAPS 2014 With Pharmaceutical Outsourcing

Summary: Todd Stutzman and John Essex discuss Catalent's OptiPactâ„¢ Technology, capabilities for Orphan Drugs, Catalent's factors of differentiation and the challenges faced by innovator companies.